Osteosarcoma in Children
Showing 1 - 25 of >10,000
3D Printed Personalized Extendable Prosthesis
Completed
- Osteosarcoma in Children
- 3D printed personalized extendable prosthesis
-
Chongqing, Chongqing, ChinaChildren's Hospital of Chongqing Medical University
Mar 30, 2023
Osteosarcoma, Osteosarcoma in Children, Osteosarcoma Recurrent Trial in United States (Regorafenib 40 MG, Regorafenib 20MG,
Recruiting
- Osteosarcoma
- +3 more
- Regorafenib 40 MG
- +2 more
-
Los Angeles, California
- +7 more
Jan 19, 2023
Osteosarcoma, Bone Tumor, Bone Sarcoma Trial
Not yet recruiting
- Osteosarcoma
- +25 more
- (no location specified)
Aug 24, 2022
Osteosarcoma in Children Trial (Dinutuximab beta)
Not yet recruiting
- Osteosarcoma in Children
- Dinutuximab beta
- (no location specified)
Sep 23, 2022
Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue Trial in United States (FoundationOne Liquid CDx)
Recruiting
- Ewing Sarcoma
- +6 more
- FoundationOne Liquid CDx
-
Los Angeles, California
- +14 more
Oct 5, 2023
Osteosarcoma Metastatic, Ewing's Sarcoma Metastatic Trial in Miami (Chemotherapy (gemcitabine & docetaxel) plus BIO-11006)
Active, not recruiting
- Osteosarcoma Metastatic
- Ewing's Sarcoma Metastatic
- Chemotherapy (gemcitabine & docetaxel) plus BIO-11006
-
Miami, FloridaNicklaus Children's Hospital
Nov 8, 2022
Osteosarcoma Trial in United States (Avelumab, Questionnaires)
Active, not recruiting
- Osteosarcoma
- Avelumab
- Questionnaires
-
Los Angeles, California
- +3 more
Aug 22, 2022
High Risk Neuroblastoma, Recurrent Neuroblastoma, Recurrent Osteosarcoma Trial in Canada, United States (Dinutuximab,
Recruiting
- High Risk Neuroblastoma
- +4 more
- Biospecimen Collection
- +6 more
-
Los Angeles, California
- +10 more
Jan 19, 2023
Sarcoma, Osteosarcoma, Neuroblastoma Trial run by the NCI (Anti-GD2-CAR engineered T cells, AP1903, Cyclophosphamide)
Completed
- Sarcoma
- +3 more
- Anti-GD2-CAR engineered T cells
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Recurrent Osteosarcoma Trial in Los Angeles, New York, Houston (humanized anti-GD2 antibody, GM-CSF)
Recruiting
- Recurrent Osteosarcoma
- humanized anti-GD2 antibody
- GM-CSF
-
Los Angeles, California
- +2 more
Dec 22, 2022
Recurrent Neuroblastoma, Recurrent Osteosarcoma, Refractory Neuroblastoma Trial in Bethesda, Seattle, Madison (Cyclophosphamide,
Recruiting
- Recurrent Neuroblastoma
- +3 more
- Cyclophosphamide
- +2 more
-
Palo Alto, California
- +3 more
Jan 25, 2023
Osteosarcoma, Recurrent Osteosarcoma Trial in United States (Trastuzumab Deruxtecan)
Suspended
- Osteosarcoma
- Recurrent Osteosarcoma
- Trastuzumab Deruxtecan
-
Birmingham, Alabama
- +27 more
Oct 21, 2022
Osteogenic Sarcoma Recurrent Trial in Hackensack, Houston (Iscador*P)
Not yet recruiting
- Osteogenic Sarcoma Recurrent
-
Hackensack, New Jersey
- +1 more
Feb 3, 2023
Drug Sensitivity and Mutation Profiling
Recruiting
- Ewing Sarcoma
- +6 more
-
Miami, FloridaNicklaus Children's Hospital
Aug 5, 2022
Ewing Sarcoma of Bone, Osteosarcoma Trial in Cairo (Tranexamic acid injection, Saline)
Recruiting
- Ewing Sarcoma of Bone
- Osteosarcoma
- Tranexamic acid injection
- Saline
-
Cairo, EgyptChildren's Cancer Hospital Egypt 57357 Cairo, Egypt
Nov 2, 2022
Osteosarcoma Trial in Toronto (High Dose Methotrexate)
Completed
- Osteosarcoma
- High Dose Methotrexate
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Oct 27, 2021
Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neuroblastoma Trial in United States (Afamitresgene
Not yet recruiting
- Synovial Sarcoma
- +3 more
- Afamitresgene autoleucel
-
Palo Alto, California
- +3 more
Dec 6, 2022
Relapsed Ewing Sarcoma, Refractory Ewing Sarcoma, Relapsed Osteosarcoma Trial in Boston (Cabozantinib, Topotecan,
Recruiting
- Relapsed Ewing Sarcoma
- +3 more
- Cabozantinib
- +3 more
-
Boston, Massachusetts
- +1 more
Sep 27, 2021
Osteosarcoma Trial in Seattle (SCRI-E2CAR_EGFRtv1, UB_TT170)
Recruiting
- Osteosarcoma
- SCRI-E2CAR_EGFRtv1
- UB_TT170
-
Seattle, WashingtonSeattle Children's Hospital
May 31, 2022
Sarcoma, Bone, Sarcoma, Soft Tissue, Osteosarcoma Trial in Memphis (Diffusion Weighted Magnetic Resonance Imaging)
Active, not recruiting
- Sarcoma, Bone
- +5 more
- Diffusion Weighted Magnetic Resonance Imaging
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 4, 2022
Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor Trial in Australia, Canada, United States (CLR 131)
Recruiting
- Pediatric Solid Tumor
- +7 more
- CLR 131
-
Palo Alto, California
- +6 more
Nov 30, 2021
ICONIC: Improving Outcomes Through Collaboration in OsteosarComa
Recruiting
- Osteosarcoma
- observational only, no interventions are prescribed in protocol.
-
London, Greater London, United Kingdom
- +17 more
Jan 19, 2022
Pediatric Renal Tumor, Metastatic Osteosarcoma, Metastatic Ewing Sarcoma Trial in Birmingham (Indocyanine green)
Recruiting
- Pediatric Renal Tumor
- +5 more
- Indocyanine green
-
Birmingham, United KingdomBirmingham children's hospital
Jun 27, 2022